ClinicalTrials.gg
Status unknownNCT03257826Updated Oct 22, 2020

The Effect of Percutaneous Kirschner Wire Technique in Management of CPT Under One Year Old

An interventional study of kirschner wire in Congenital Pseudarthrosis of Tibia, sponsored by Hunan Children's Hospital. Status unknown at 1 site in China. Open to participants aged 1 Month to 12 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-10-22.

Sponsored by Hunan Children's Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2020), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Aug 2015, registered Aug 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
1 Month to 12 Months
Sex
All
01

Study summary

The aim of this study was to investigate the effect of percutaneous kirschner wire in management of Congenital Pseudarthrosis of Tibia in children younger than 1 year of age. This study was to determine the union rates of congenital pseudarthrosis in children operated before 1 year of age to identify growth abnormalities in the affected limb ,including ankle valgus,tibia valgus,and shortening.

Read the detailed description

Currently, the timing of surgery for congenital pseudarthrosis of the tibia is a controversial issue. The investigators use percutaneous kirschner wire technique to manage the Congenital Pseudarthrosis of Tibia in children younger than 1 year of age.To investigate the effect of percutaneous kirschner wire in management of Congenital Pseudarthrosis of Tibia in children younger than 1 year of age. Bone uion rate,average time of healing, ankle valgus, limb length discrepancy, tibia axis alignment are recorded and evaluated.

02

Conditions studied

  • Congenital Pseudarthrosis of Tibia

Browse trials for

Keywords

  • congenital pseudarthrosis of the tibia
  • age of surgery
  • Percutaneous Kirschner wire
03

In context

Pseudarthrosis

41 studies on the registry are indexed under Pseudarthrosis; 7 are open to participants now.

This study's planned enrollment of 100 is above the median of 22 across 25 interventional studies indexed under Pseudarthrosis.

Browse Pseudarthrosis studies →

Lead sponsor

Hunan Children's Hospital is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 12 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients did not undergo procedures
  • Patients with Crawford type IV CPT treated with Percutaneous Kirschner wire techniques
  • The age during surgery was less than 12 months old

Exclusion criteria

Exclusion Criteria:

  • Patients with pseudarthrosis of tibia caused by trauma,infection, etc
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    surgery

    Percutaneous Kirschner wire

    Device: kirschner wire

Interventions

  • Devicekirschner wire

    retrograde percutaneous kirschner wire was applied to stabilize the tibia.

06

What researchers measure

Primary outcomes

  1. Primary union score (range,4-12 score)

    X ray score from tibia pseudarthrosis in anterior and posterior (AP )and lateral X ray. ("RUST" score:radiographic union scoring system for tibial fracture healing)

    Time frame: 9 months post-operation

Secondary outcomes

  1. Refracture(Cortical discontinuity)

    Refracture was defined as an obvious fracture(Cortical discontinuity) on a plain radiograph,following the union at the site of the tibia.

    Time frame: 0.5 , 1,2,3,4,5,6,7,8,9,10 years after the fracture is healed

  2. Residual Deformity-proximal tibia angulation(range,0°-90°)

    measurement of the angulation of proximal tibia in anterior and posterior (AP )and lateral X ray.Proximal tibial valgus is created by the intersection of a line parallel to the proximal physis and another line along the axis of the proximal third of diaphysis in the tibia.

    Time frame: pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation ]

  3. Residual Deformity-Limb length discrepancy

    measurement of the length difference of both tibia in AP and lateral X ray.Picture Archiving and Communication System (PACS) is used to measure the length of the tibia (The investigators measure the distance between the midpoint of the proximal tibial epiphyseal plate and the midpoint of distal tibia epiphyseal plate).

    Time frame: pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation

  4. Residual Deformity-ankle valgus angulation(range,0°-90°)

    measurement of the angulation between the distal tibia and ankle joint.Ankle valgus is assessed by the tibiotalar angle measured at the intersection of the mid-diaphyseal line of the tibia and a line drawn across the flat subchondral line of the talar dome.

    Time frame: pre-operation and 0.5 , 1,2,3,4,5,6,7,8,9,10 years post-operation

07

Study locations

1 of 1 sites recruiting
  • Kun Liu
    Changsha, Hunan 417000, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03257826
Lead sponsor
Hunan Children's Hospital
Collaborators
Guangzhou Women and Children's Medical Center, Shenzhen Children's Hospital, Tongji Hospital, Wuhan Union Hospital, China, Wuhan Women and Children's Medical Center, Foshan Hospital of Traditional Chinese Medicine, Dalian Children's Hospital, Children's Hospital of Chongqing Medical University, Kunming Children's Hospital
Responsible party
Sponsor
First posted
Aug 22, 2017
Start date
Aug 1, 2015
Primary completion
Dec 1, 2022 (estimated)
Completion
Dec 1, 2022 (estimated)
Last update
Oct 22, 2020

Study contacts

Kun Liu, MD
Contact
lk998@sina.com
008615084796158
Haibo Mei, MD
Contact
meihaibo@sina.com
008613975197731
Haibo Mei, MD
study director · Hunan Children's Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion